Description: Unity Biotechnology Inc operates as a biotechnology company. The firm focuses on age-associated diseases such as arthritis, vision loss and cognitive decline.
Home Page: unitybiotechnology.com
UBX Technical Analysis
285 East Grand Avenue
South San Francisco,
CA
94080
United States
Phone:
650 416 1192
Officers
| Name | Title |
|---|---|
| Dr. Anirvan Ghosh Ph.D. | CEO & Director |
| Dr. Nathaniel E. David A.B., Ph.D. | Co-Founder & Exec. Director |
| Ms. Lynne Marie Sullivan | CFO & Head of Corp. Devel. |
| Dr. Jamie Dananberg M.D. | Chief Medical Officer |
| Dr. Jan M. van Deursen | Founder |
| Dr. Judith Campisi Ph.D. | Founder |
| Mr. Daohong Zhou M.D. | Founder |
| Mr. Nathan Guz Ph.D. | VP of Operations |
| Mr. Alexander Azoy | VP of Fin., Chief Accounting Officer, Controller & Principal Accounting Officer |
| Dr. Przemyslaw Sapieha Ph.D. | Chief Scientific Advisor |
Exchange: NASDAQ
Country: US : United States of America
Currency: US Dollar ($)
| GIC Sector: | Health Care |
|---|---|
| GIC Group: | Pharmaceuticals, Biotechnology & Life Sciences |
| GIC Industry: | Biotechnology |
| GIC Sub-Industry: | Biotechnology |
| Forward PE: | 0 |
|---|---|
| Trailing PE: | 0 |
| Price-to-Book MRQ: | 0.5203 |
| Price-to-Sales TTM: | 7.8878 |
| IPO Date: | 2018-05-03 |
| Fiscal Year End: | December |
| Full Time Employees: | 65 |